finalfantasy7
First Class Player
- Joined
- Jan 19, 2011
- Runs
- 3,180
India having trouble with thr covid booking system:
https://www.wired.co.uk/article/india-covid-vaccine-cowin
https://www.wired.co.uk/article/india-covid-vaccine-cowin
Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
How come india is ordering 300m unapproved jabs,
India has ordered 300 million doses of an unapproved coronavirus vaccine amid a devastating second wave.
The unnamed vaccine from Indian firm Biological E is in Phase 3 trials, and had showed "promising results" in the first two phases, the federal government said in a statement.
The $206m order is the first India has signed for a jab that has not received emergency approval.
This comes as the country struggles to speed up its lagging vaccine drive.
India has administered just over 220 million jabs so far although much of its 1.4 billion population is now eligible for the vaccine. Less than 10% of the country has received at least one dose of the vaccination, largely because of a severe shortage of doses.
Although Covid case numbers have been dropping, India is still adding more than 100,000 news cases a day. It has recorded more than 340,000 deaths from the virus so far, but experts say the number is vastly underestimated.
India's federal government, led by Prime Minister Narendra Modi, has been criticised for not placing huge orders ahead of time with either Indian or foreign vaccine makers.
ndia is currently giving three vaccines - Covishield, manufactured by the Serum Institute of India (SII), and Covaxin, developed by Indian firm Bharat Biotech and the government's Indian Council of Medical Research, and Sputnik V, which is developed by Moscow's Gamaleya Institute.
Compared to the single order from Biological E for 300 million doses, India brought about 350 million doses from both Covishield and Covaxin between January and May.
India's drug regulator gave Covaxin emergency approval in January before trials were completed - data on its efficacy is yet to be released.
The new vaccine from Biological E is "likely to be available in the next few months," according to the government
Mr Modi's government is racing to shore up its vaccine stocks as Covid numbers dip, hoping to be well-prepared for what experts say is an inevitable third wave.
India's vaccine drive, which had a promising start in January, began to slow down because vaccine hesitancy crept in as cases dropped. But numbers soon rose again in a deadly second wave that saw hospitals falling short of beds and crematoriums running short of space.
Hoping to stem the tide, the government threw open the drive in May to everyone above the age of 18 but India's two vaccine makers - Serum Institute and Bharat Biotech - could not guarantee supply at that scale.
But shortages persist and have also led to vast inequalities in access with rural areas, the poor and women falling behind in the line for jabs.
https://www.bbc.co.uk/news/world-asia-india-57354069
Another hit job by BBC. Countries pre ordered Pfizer Moderna,AZ etc vaccines. This kind of hit jobs that create panic in midst of a pandemic, needs to be dealt with strictly.
How come india is ordering 300m unapproved jabs,
India has ordered 300 million doses of an unapproved coronavirus vaccine amid a devastating second wave.
The unnamed vaccine from Indian firm Biological E is in Phase 3 trials, and had showed "promising results" in the first two phases, the federal government said in a statement.
The $206m order is the first India has signed for a jab that has not received emergency approval.
This comes as the country struggles to speed up its lagging vaccine drive.
India has administered just over 220 million jabs so far although much of its 1.4 billion population is now eligible for the vaccine. Less than 10% of the country has received at least one dose of the vaccination, largely because of a severe shortage of doses.
Although Covid case numbers have been dropping, India is still adding more than 100,000 news cases a day. It has recorded more than 340,000 deaths from the virus so far, but experts say the number is vastly underestimated.
India's federal government, led by Prime Minister Narendra Modi, has been criticised for not placing huge orders ahead of time with either Indian or foreign vaccine makers.
ndia is currently giving three vaccines - Covishield, manufactured by the Serum Institute of India (SII), and Covaxin, developed by Indian firm Bharat Biotech and the government's Indian Council of Medical Research, and Sputnik V, which is developed by Moscow's Gamaleya Institute.
Compared to the single order from Biological E for 300 million doses, India brought about 350 million doses from both Covishield and Covaxin between January and May.
India's drug regulator gave Covaxin emergency approval in January before trials were completed - data on its efficacy is yet to be released.
The new vaccine from Biological E is "likely to be available in the next few months," according to the government
Mr Modi's government is racing to shore up its vaccine stocks as Covid numbers dip, hoping to be well-prepared for what experts say is an inevitable third wave.
India's vaccine drive, which had a promising start in January, began to slow down because vaccine hesitancy crept in as cases dropped. But numbers soon rose again in a deadly second wave that saw hospitals falling short of beds and crematoriums running short of space.
Hoping to stem the tide, the government threw open the drive in May to everyone above the age of 18 but India's two vaccine makers - Serum Institute and Bharat Biotech - could not guarantee supply at that scale.
But shortages persist and have also led to vast inequalities in access with rural areas, the poor and women falling behind in the line for jabs.
https://www.bbc.co.uk/news/world-asia-india-57354069
thats because they work, they were only allowed onto the market, for the reason
read the bold part - joshilla
read the bold part - joshilla
BBC has contradictory articles from their own journalist.
Markets and shopping malls in New Delhi will be allowed to reopen from Monday in a further easing of the COVID-19 lockdown, the chief minister of the national capital territory said as infections fall in major Indian cities after weeks of restrictions.
Delhi Metro will also resume services at 50 percent capacity, Delhi Chief Minister Arvind Kejriwal said on Saturday. Markets and malls will operate on alternate days, with half of them open on any given day.
Offices can also reopen at half capacity but Kejriwal urged people to still try to work from home.
The easing comes after Delhi allowed construction sites and factories to reopen last week.
“They have been open for a week but the COVID-19 situation is still under control, and we have less than 500 fresh cases in the last 24 hours,” Kejriwal said. “It is important to bring the economy back on track now that the COVID-19 situation improving. We pray that the situation remains the same.”
The government of Maharashtra state, which includes India’s economic hub of Mumbai, announced a five-level plan to ease restrictions depending on infection rates and hospital bed occupancy.
In level-one areas – with infection rates below five percent and hospital bed occupancy below 25 percent – all shops, restaurants and malls will be allowed to reopen.
But level-five districts – with infection rates over 20 percent – will remain under severe movement restrictions.
Daily infections reported across India have dropped to about 120,000 from more than 400,000 in May, according to official statistics.
Deaths have also fallen, with 3,380 reported in the previous 24 hours, although this is widely seen as a major underestimate. At least 344,082 people in the country have lost their lives to the coronavirus, which is now surging in parts of rural India.
Delhi reported about 400 new infections on Saturday, down from about 25,000 daily cases when the lockdown was announced seven weeks earlier. The devastating surge was blamed on new virus variants and the government having allowed most activity to return to normal including mass religious and political gatherings.
India’s vaccination programme, meanwhile, is making slow progress due to shortages, confusion and squabbling between the central government and state authorities.
So far about 180 million people, only 14 percent of the population, have received one dose, and 45 million, or 3.4 percent, two shots.
When western countries put in pre orders of vaccines under trials it was anticipation, India does it, its dangerous. The more the government orders local vaccines, lesser is the market for foreign players like Pfizer.
Its nothing to do with Pakistan, the propoganda to help some foreign vaccine makers is quite clear.
"The COVID-19 pandemic is a result of the degradation of natural areas, species’ loss and exploitation."
medical scientist are still trying to solve the mystery but there you go, environmentalist already declared the root cause. It feels like rakhi Sawant who would incorporate herself to anything to stay relevant. Covid 19 has shifted the focus from environment which was going prior and now, they are still trying the same trick.
How can environment go worse here?
Due to curfew, the cars and buses are way less than it was. Most factories are closed. The animal industry is partial functioning. The railway is partially working. what else I missed?
Can someone tell me how short term strategy (whatever it is) is affecting the environment? If it's short term, then why so much worry (even if it does) since it will be a temporary anyway regardless on the impact. And environment isn't an entity which you can drastically change over few years.
Can someone decipher it because I seem to not understand it at all.
India has reported 46,148 new Covid-19 infections over the past 24 hours, data from the health ministry showed.
The South Asian country's total Covid-19 caseload now stands at 30.27 million, while total fatalities are at 396,730, the data showed.
India's coronavirus-related deaths rose by 979 overnight, according to Reuters.
From 300k per day (which some say was under reported) down to 46k in a matter of weeks. Sounds like a miracle to me.
From 300k per day (which some say was under reported) down to 46k in a matter of weeks. Sounds like a miracle to me.
I wonder how BBC picks up random doctors who seem to parrot what BBC wants to hear.
The Covid-19 pandemic has caused excess deaths in India to cross more than four million, a new study has found.
Excess deaths are a measure of how many more people are dying than would be expected compared to the previous few years.
Although it is difficult to say how many of these deaths have been caused by Covid-19, they are a measure of the overall impact of the pandemic.
India has officially recorded more than 414,000 Covid-19 deaths so far.
The country is one of the few major economies without an estimate of excess deaths during the pandemic.
Researchers from the US-based Center for Global Development used three different data sources to estimate India's excess all-cause mortality during the pandemic until 21 June.
They extrapolated death registrations from seven states, accounting for half of India's population. India conducts yearly mortality surveys but has only published numbers up to 2019.
Second, the researchers applied international estimates of age-specific infection fatality rates - the number of people that die from the virus - to data from two countrywide antibody tests, also called sero surveys.
Third, they looked at India's consumer survey of 868,000 individuals across 177,000 households which also records whether any member of the family had died in the past four months.
Taken together, the researchers found that excess deaths were estimated to be in the range of 3.4 million to 4.7 million - about 10 times higher than India's official Covid-19 death toll.
This was also considerably higher than other estimates by epidemiologists, who believed India's excess deaths were five-to-seven times higher.
Not all these deaths were caused by Covid-19 and an estimation of the actual death toll by the disease would be difficult to give, said Arvind Subramanian, India's former chief economic adviser and one of the authors of the study.
Although data on how many people died in the pandemic was patchy, researchers looked at the data on infection rates, based on many sero surveys to get a ballpark estimate of deaths.
They took India's infection numbers and applied estimates from international studies of the probability of death after a Covid-19 infection.
They did this with each different age group, applying international estimates of the Covid-19 infection fatality rate at a given age to the number of infections among Indians in that age group.
The data implied that four million people had died in the pandemic in India, according to Dr Subramanian.
"Two of our three estimates measure all-cause mortality and not Covid-19 deaths. Our second measure is a bit closer to a number of [actual] Covid-19 deaths, but it is only one of three estimates," Dr Subramanian told me.
The researchers - including Justin Sandefur of the Center for Global Development and Abhishek Anand of Harvard University - also said that the first wave last year appeared to have been more lethal than what was popularly believed. Mortality appeared to be moderate because it was "spread out in time and space".
Dr Subramanian said one of the conclusions might be that "India has not been an outlier" and has had "mortality not dissimilar from countries of comparable size and infections".
The researchers said the most "critical take-away, regardless of the sources and estimates", was that actual deaths during the Covid-19 pandemic were "likely to be far greater than the official count".
"The true deaths are likely to be in several millions, not hundreds of thousands, making this arguably India's worst human tragedy since the partition and independence."
Whiff of fresh air this Morrison guy is!
While here we have someone who only knows how to take credit of successes, not failures! For the latter, he sacks his health minister instead.